Q: My friend says his uncle is being treated for a disease where he has too much blood and he gets "bloodletting’" every other day, like in the Middle Ages. Is there really such a thing, or is he ...

A panelist discusses how patients with polycythemia vera (PV) often present with diverse symptoms ranging from fatigue and itching to cardiovascular complications, leading doctors to conduct specific ...

Polycythemia vera is a classic myeloproliferative neoplasm and a chronic type of leukemia, which often leads to overproduction of various blood cells. In this interview, Andrew Kuykendall, MD, ...

Raajit Rampal, MD, PhD, of Memorial Sloan Kettering Cancer Center, discusses the potential of a disease-modifying therapy in polycythemia vera, treating high-risk vs low-risk patients, and emerging ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Polycythemia Vera pipeline constitutes 8+ key ...

A high red blood cell count can occur for many reasons, including excessive cell production, changes in blood volume, or underlying medical conditions. Sometimes, the cause is unknown. Erythrocytes, ...

Q: I am an active woman and keep up my own house, both inside and outside. About a month ago, I began to get tired doing chores. Around the same time, I developed an unspeakable itch after bathing. My ...

Hi. I'm Ron. I'm a polycythemia patient. I was diagnosed at the age of 38 and have been living with the disease for over 25 years. As you go along with your treatment as a polycythemia patient, you ...

CHICAGO -- The use of the investigational weekly subcutaneous injection rusfertide significantly reduced the need for phlebotomy among polycythemia vera patients who had been dependent on it, the ...

VIENNA--(BUSINESS WIRE)--AOP Orphan Pharmaceuticals GmbH (AOP Health) announced the publication of final results on the recently developed interferon therapy, ropeginterferon alfa-2b, in patients with ...

TAIPEI--(BUSINESS WIRE)--PharmaEssentia Corporation (TPEx:6446), a leading fully integrated biopharmaceutical company in Taiwan, today announced the publication of new results from a Phase 2 clinical ...